Noveris Health Sciences Inc. Unaware Of Any Material Change

Vancouver, British Columbia, March 16, 2026 – TheNewswire - At the request of CIRO, Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. The Company is a biotechnology company focused on discovering and developing medications and therapies to address mental health disorders, including nicotine addiction and posttraumatic stress disorder (PTSD). The Company's objective is to use a blend of advanced technology with an elaborate infrastructure to speed up the development of breakthrough medications to provide patients with safer and more effective treatment solutions.